Add to ORKGMckenzie Taylor continues our monthly conversation on the strategies presented in The Trump Administration Blueprint to Low Drug Prices and Reduce Out-of-Pocket Costs, discussing the ways new negotiations between payers and manufacturers are helping to reduce drug prices
Throughout the United States, escalating drug prices are putting immense pressure on state budgets. ...
The United States is the foremost innovator of pharmaceutical therapies in the world. That innovatio...
The development and distribution of pharmaceuticals from conception to market is a complicated and h...
Prohibiting gag clauses could help lower consumer out-of-pocket pharmacy costs - if Pharmacy Benefit...
Earlier this year, the Department of Health and Human Services (HHS) proposed changes to the current...
The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs calls for inc...
The cost of brand-name drugs in the United States is up to four times higher than in other countries...
Congress may reform drug pricing policies under Medicare Part D as part of a larger health reform ef...
Under the 2022 Inflation Reduction Act, the Centers for Medicare and Medicaid Services (CMS) are abl...
Background: Drug prices in the United States are the highest in the world, restricting access to the...
The United States is a relatively free-pricing market for pharmaceutical manufacturers to set list p...
The United States healthcare system is one of the most expensive in the world. Unlike other products...
When Congress was debating the Medicare drug benefit in 2003, there were many who advocated that Med...
Testimony issued by the Government Accountability Office with an abstract that begins "Rising prescr...
The Medicare Prescription Drug, Improvement, and Modernization Act (MMA) expressly forbids the Secr...
Throughout the United States, escalating drug prices are putting immense pressure on state budgets. ...
The United States is the foremost innovator of pharmaceutical therapies in the world. That innovatio...
The development and distribution of pharmaceuticals from conception to market is a complicated and h...
Prohibiting gag clauses could help lower consumer out-of-pocket pharmacy costs - if Pharmacy Benefit...
Earlier this year, the Department of Health and Human Services (HHS) proposed changes to the current...
The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs calls for inc...
The cost of brand-name drugs in the United States is up to four times higher than in other countries...
Congress may reform drug pricing policies under Medicare Part D as part of a larger health reform ef...
Under the 2022 Inflation Reduction Act, the Centers for Medicare and Medicaid Services (CMS) are abl...
Background: Drug prices in the United States are the highest in the world, restricting access to the...
The United States is a relatively free-pricing market for pharmaceutical manufacturers to set list p...
The United States healthcare system is one of the most expensive in the world. Unlike other products...
When Congress was debating the Medicare drug benefit in 2003, there were many who advocated that Med...
Testimony issued by the Government Accountability Office with an abstract that begins "Rising prescr...
The Medicare Prescription Drug, Improvement, and Modernization Act (MMA) expressly forbids the Secr...
Throughout the United States, escalating drug prices are putting immense pressure on state budgets. ...
The United States is the foremost innovator of pharmaceutical therapies in the world. That innovatio...
The development and distribution of pharmaceuticals from conception to market is a complicated and h...